跳至主要内容
临床试验/EUCTR2006-003957-25-IT
EUCTR2006-003957-25-IT进行中(未招募)不适用

Rare Diseases with microvascular involvement. High Dose Intravenous N-acetylcysteine versus Iloprost for early, rapidlyprogressive diffuse Systemic Sclerosis (Scleroderma) - N-Acetylcisteine vs Iloprost in SSc

AZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI0 个研究点开始时间: 2007年7月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • a. edSSc (ACR criteria);
  • b. age 18-80 years;
  • c. ability to give an informed consent;
  • d. use of an acceptable method of birth control (if women in childbearing age).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • a. connective tissue diseases other than SSc;
  • b. history of intolerance to the study drugs;
  • c. severe cardiac failure (NYHA >=3 or left ventricular ejection fraction <40%), recent (<6 months) history of myocardial
  • infarction; symptomatic ischemic myocardial disease, ventricular tachyarrhythmia, atrial fibrillation;
  • d. resting PaO2 <60mm/hg or Carbon Monoxide Diffusing Capacity <40% of predicted
  • e. creatinina clearance below 90ml/h
  • f. ALT or bilirubin above two times upper normal limits;
  • g. bronchial asthma;
  • h. hemorrhagic diathesis

研究者

发起方
AZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI

相似试验